Published on 12 November 2023
The SCANPatient clinical trial is now running at 33 hospitals involved in the management of pancreas adenocarcinoma in Victoria, Queensland, New South Wales, Western Australia, Canberra, Tasmania and South Australia.
The SCANPatient study is a Medical Research Future Fund (MRFF) supported randomised clinical trial (RCT), which compares the standard narrative style radiological report with an alternative standardised approach for reporting CT scans of the pancreas in suspected Pancreas Ductal Adenocarcinoma (PDAC). The aim is to determine whether this standardised synoptic report will result in more accurate diagnosis of localised PDAC to improve delivery of care.
Since the 1st of July 2023, the SCANPatient study has recruited over 270 PDAC patients. By the end of the study, we expect to have data from conservatively more than 2000 patients with PDAC over the 3 years.
For more information